Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open Multicentre Study for Assessment of the Safety and Efficacy Against COVID-19 of the Drug JTBC00201 (PROMOMED RUS LLC, Russia) in the Adult Population

NCT05601167 is registered in ClinicalTrials.gov with Promomed, LLC as lead sponsor.

NCT NCT05601167
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05601167 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open Multicentre Study for Assessment of the Safety and Efficacy Against COVID-19 of the Drug JTBC00201 (PROMOMED RUS LLC, Russia) in the Adult Population
Lead sponsor
Promomed, LLC
Phase
Phase 3
Overall status
Completed
Start date
February 17, 2021
Completion date
June 1, 2022
Enrollment
264 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19